Key facts
- It has raised $16.5M; the latest was Later Stage VC ($10.8M) in Jun 2024.
- Notable investors include Altana (Germany), SPV Investments, Taaleri, Taaleri Bioindustry, UB FIGG.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Nordtreat
- ·The full record, as it builds
Funding rounds
No funding rounds for Nordtreat are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nordtreat
Manufacturer of chemicals intended to provide fire protection for building materials made from renewable raw materials. The company specializes in making fire retardant chemicals based on non-toxic bio-based acids, especially for wood construction, by replacing traditional retardants that contain compounds that are harmful to humans and the environment, enabling companies to use eco-friendly elements for wood products.
- Sector
- Materials and Resources
- HQ
- Vantaa, Finland
- Founded
- 2015
- Employees
- 23
- Website
- nordtreat.com/
- Ownership
- Privately Held (backing)
Nordtreat doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nordtreat shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nordtreat in its N-PORT filings yet. We sweep new filings monthly.